ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
Operating Expenses
ATAI Life Sciences NV
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Operating Expenses
-$125.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Operating Expenses
-€26.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
Merck KGaA
XETRA:MRK
|
Operating Expenses
-€8.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
MPH Health Care AG
XETRA:93M1
|
Operating Expenses
-€1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Operating Expenses
-€541.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Operating Expenses
-€67m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
See Also
What is ATAI Life Sciences NV's Operating Expenses?
Operating Expenses
-125.8m
USD
Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Operating Expenses amounts to -125.8m USD.
What is ATAI Life Sciences NV's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-11%
Over the last year, the Operating Expenses growth was 13%. The average annual Operating Expenses growth rates for ATAI Life Sciences NV have been -11% over the past three years .